Alzamend Neuro, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€8.58M -33.1% N/A -€7.01M -9.0% N/A
    €0.00 +NaN% -€12.83M +20.4% N/A -€7.70M +37.1% N/A
    €0.00 +NaN% -€10.66M +144.9% N/A -€5.61M +140.0% N/A
    €0.00 +NaN% -€4.35M +14.4% N/A -€2.34M +15.6% N/A
    €0.00 +NaN% -€3.80M -9.3% N/A -€2.02M +124.4% N/A
    €0.00 +NaN% -€4.19M +421.7% N/A -€901.58K -49.1% N/A
    €0.00 +NaN% -€803.93K -40.6% N/A -€1.77M +44.8% N/A
    €0.00 +NaN% -€1.35M +2,160.4% N/A -€1.22M +7,561.1% N/A
    €0.00 -€59.91K N/A -€15.95K N/A

    Notifications